KAYLAH BLACK: Open Payments
NPI 1104337021 · CARY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,666 in 126 payments from 21 companies in 2025. Trend: 2023 $2,974 · 2024 $2,483 · 2025 $2,666
Food & beverage: $2,582Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $665 |
| Janssen Biotech, Inc. | 14 | $333 |
| Regeneron Healthcare Solutions, Inc. | 8 | $238 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $227 |
| Madrigal Pharmaceuticals | 8 | $190 |
| GENZYME CORPORATION | 6 | $156 |
| QOL Medical, LLC | 7 | $118 |
| Ipsen Biopharmaceuticals, Inc | 4 | $102 |
| Lilly USA, LLC | 5 | $96 |
| PFIZER INC. | 5 | $93 |
Products named: DUPIXENT, TREMFYA, RINVOQ, REZDIFFRA, CREON, XIFAXAN, Sucraid, SKYRIZI.
Industry payments across NC — which companies pay providers there.
